Choksi Laboratories Limited (BOM:526546)
India flag India · Delayed Price · Currency is INR
134.55
+2.30 (1.74%)
At close: Aug 21, 2026

Choksi Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
468.27460.06417.82366.95344.41300.42
Revenue Growth
10.73%10.11%13.86%6.55%14.64%16.95%
Gross Profit
191.6185.21217.08195.87188.46160.49
Operating Income
51.3650.4747.4845.1347.4334.67
Net Income
21.6219.6415.2311.132.12.07
Earnings Per Share
3.112.822.191.594.610.30
EPS Growth
45.40%28.94%37.55%-65.50%1450.73%-

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2.072.076.126.626.054.07
Total Debt
341.7341.7291.57308.73324.16372.89
Net Cash (Debt)
-339.63-339.63-285.44-302.11-318.11-368.82
Net Cash Growth
------
Net Cash Per Share
-48.88-48.76-40.98-43.38-45.67-52.95

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-78.65117.78115.5282.5478.77
Capital Expenditures
--79.77-74.39-70.05-39.53-26.8
Free Cash Flow
--1.1343.3945.4743.0151.98
Free Cash Flow Growth
---4.58%5.72%-17.26%-

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
40.92%40.26%51.95%53.38%54.72%53.42%
Operating Margin
10.97%10.97%11.36%12.30%13.77%11.54%
Pretax Margin
6.76%6.94%5.15%4.53%10.81%1.22%
Profit Margin
4.62%4.27%3.65%3.02%9.32%0.69%
FCF Margin
--0.24%10.38%12.39%12.49%17.30%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
43.2536.7354.9426.607.2685.47
P/FCF Ratio
--19.296.495.423.40
PS Ratio
2.001.572.000.800.680.59